EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A precision image-guided model of stereotactic ablative radiotherapy for hepatocellular carcinoma

Stephanie May iD, Katrina Stevenson iD, Bashaer Alqarafi iD, Kyi Lai Yin Swe iD, Algernon Bloom iD, Agata Mackintosh, Miryam Müller iD, Anastasia Georgakopoulou iD, Thomas M Drake iD, Christos Kiourtis iD, Saadia A Karim iD, Colin Nixon iD und 7 weitere

Disease Models & Mechanisms · 01.05.2025 · 18 (5)

DOI: 10.1242/dmm.052301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease Models & Mechanisms, online erschienen am 19.05.2025. Verfasst von Stephanie May und 18 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research UK Scotland Institute, Glasgow G61 1BD, UK. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Radiosurgery, Liver Neoplasms, Radiotherapy, Image-Guided. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Wellcome Trust, University of Glasgow.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver tumours, both primary and metastatic, are diseases of unmet clinical need. Hepatocellular carcinoma (HCC), the most common primary liver tumour, like many other cancers, can be treated by stereotactic ablative radiotherapy (SABR), reducing off-target effects of radiation on local anatomical structures. However, integrating all the necessary components for stereotactic irradiation of HCC in murine models has not yet been reported. Here, we provide the development and detailed characterisation of a murine SABR model combining magnetic resonance imaging- and computed tomography (CT)-guided delineation of the tumour, together with CT-guided liver tumour radiotherapy. The model enables accurate delivery of clinically relevant doses of radiotherapy with good tolerability and on-target tumour responses in models with otherwise universally progressive disease. The development of this preclinical modelling platform paves the way for its integration into multimodal therapeutic and mechanistic testing in preclinical murine models of metastatic and primary liver tumours, including HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularRadiosurgeryLiver NeoplasmsRadiotherapy, Image-GuidedAnimalsMagnetic Resonance ImagingTomography, X-Ray ComputedMiceDisease Models, AnimalHumans

Stichwörter der Autor:innen

CT imagingCancerHepatocellular carcinomaMultimodal therapyPreclinical modelStereotactic ablative radiotherapy

Autor:innen und Institutionen

  • Cancer Research UK Scotland Institute, Glasgow G61 1BD, UK.
  • School of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK.
  • Cancer Research UK Scotland Centre, Glasgow G61 1BD, UK.
  • Department of Clinical Oncology, Beatson West of Scotland Cancer Centre, Glasgow G12 0YN, UK.
  • Centre for Inflammation Research, University of Edinburgh, Edinburgh EH16 4UU, UK.
  • CRUK Scotland Centre, Edinburgh EH4 2XR, UK.

ORCID-Profile: Stephanie May, Katrina Stevenson, Bashaer Alqarafi, Kyi Lai Yin Swe, Algernon Bloom, Miryam Müller, Anastasia Georgakopoulou, Thomas M Drake, Christos Kiourtis, Saadia A Karim, Colin Nixon, Aileen Duffton, Derek Grose, David Y Lewis, Karen Blyth, Anthony J Chalmers, Thomas G Bird

Förderung

  • Cancer Research UK
  • Wellcome Trust
  • University of Glasgow
  • Beatson Cancer Charity
  • Cancer Research UK radiation research network

Zitieren

APA

May, S., Stevenson, K., Alqarafi, B., Yin Swe, K. L., Bloom, A., Mackintosh, A., Müller, M., Georgakopoulou, A., Drake, T. M., Kiourtis, C., Karim, S. A., Nixon, C., Cadden, B., Duffton, A., Grose, D., Lewis, D. Y., Blyth, K., Chalmers, A. J., & Bird, T. G. (2025). A precision image-guided model of stereotactic ablative radiotherapy for hepatocellular carcinoma. Disease Models & Mechanisms, 18(5). https://doi.org/10.1242/dmm.052301

Vancouver

May S, Stevenson K, Alqarafi B, Yin Swe KL, Bloom A, Mackintosh A, et al. A precision image-guided model of stereotactic ablative radiotherapy for hepatocellular carcinoma. Disease Models & Mechanisms. 2025;18(5). doi:10.1242/dmm.052301

BibTeX
@article{May2025,
  author = {May, Stephanie and Stevenson, Katrina and Alqarafi, Bashaer and Yin Swe, Kyi Lai and Bloom, Algernon and Mackintosh, Agata and Müller, Miryam and Georgakopoulou, Anastasia and Drake, Thomas M and Kiourtis, Christos and Karim, Saadia A and Nixon, Colin and Cadden, Barbara and Duffton, Aileen and Grose, Derek and Lewis, David Y and Blyth, Karen and Chalmers, Anthony J and Bird, Thomas G},
  title = {A precision image-guided model of stereotactic ablative radiotherapy for hepatocellular carcinoma},
  journal = {Disease Models & Mechanisms},
  year = {2025},
  volume = {18},
  number = {5},
  doi = {10.1242/dmm.052301}
}
Kostenlos starten →